Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and ach 702

thiazoles has been researched along with ach 702 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molina-Torres, CA; Ocampo-Candiani, J; Pucci, MJ; Rendón, A; Vera-Cabrera, L1
Campos-Rivera, MP; Escalante-Fuentes, WG; Ocampo-Candiani, J; Pucci, MJ; Vera-Cabrera, L; Welsh, O1
Ackerman, M; Cynamon, MH; Pucci, MJ; Shoen, CM; Thanassi, JA1
Bradbury, BJ; Deshpande, M; Leggio, MJ; Podos, SD; Pucci, MJ; Thanassi, JA1
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA1
Barba-Marines, A; Castro-Garza, J; Cavazos-Rocha, N; Molina-Torres, CA; Ocampo-Candiani, J; Pucci, MJ; Valles-Guerra, O; Vera-Cabrera, L1

Other Studies

6 other study(ies) available for thiazoles and ach 702

ArticleYear
In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium kansasii; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Quinolones; Thiazoles

2010
In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Econazole; Humans; Imipenem; In Vitro Techniques; Meropenem; Mycetoma; Nocardia; Nocardia Infections; Quinolones; Thiazoles; Thienamycins

2010
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolones; Thiazoles; Topoisomerase II Inhibitors; Tuberculosis

2010
In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteria; DNA Replication; DNA Topoisomerase IV; Female; Humans; Mice; Microbial Sensitivity Tests; Quinolones; Staphylococcus aureus; Thiazoles; Topoisomerase II Inhibitors

2011
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:7

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin

2012
Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages.
    Annals of clinical microbiology and antimicrobials, 2014, Apr-04, Volume: 13

    Topics: Antitubercular Agents; Bacterial Load; Cell Line; Humans; Macrophages; Mycobacterium tuberculosis; Organophosphates; Oxazoles; Quinolones; Thiazoles

2014